Elevated 5-HT 2A Receptors in Postmortem Prefrontal Cortex in Major Depression is Associated with Reduced Activity of Protein Kinase A

Overview

Journal Neuroscience

Specialty Neurology

Date 2008 Dec 30

PMID 19111907

Citations 63

Authors

R C Shelton

E Sanders-Bush

D H Manier

D A Lewis

Affiliations

Soon will be listed here.

Abstract

Previous human postmortem brain tissue research has implicated abnormalities of 5-HT receptor availability in depression and suicide. Although altered abundance of 5-HT 1A, 5-HT 2A, and 5-HT 2C receptors (5-HT(1A), 5-HT(2A), and 5-HT(2C)) has been reported, the causes remain obscure. This study evaluated the availability of these three receptor subtypes in postmortem brain tissue specimens from persons with a history of major depression (MDD) and normal controls and tested the relationships to protein kinases A and C (PKA, PKC). Samples were obtained from postmortem brain tissue (Brodmann area 10) from 20 persons with a history of MDD and 20 matched controls as determined by a retrospective diagnostic evaluation obtained from family members. Levels of 5-HT(1A), 5-HT(2A), and 5-HT(2C) receptor were quantitated via Western blot analyses. Basal and stimulated PKA and PKC activity were also determined. The depressed samples showed significantly increased 5-HT(2A) receptor abundance relative to controls, but no differences in 5-HT(1A) or 5-HT(2C) receptors. Basal and cyclic AMP-stimulated PKA activity was also reduced in the depressed sample; PKC activity was not different between groups. 5-HT(2A) receptor availability was significantly inversely correlated with PKC activity in controls, but with PKA activity in the depressed sample. Increased 5-HT(2A) receptor abundance and decreased PKA activity in the depressed sample are consistent with prior reports. The correlation of 5-HT(2A) receptor levels with PKA activity in the depressed group suggests that abnormalities of 5-HT(2A) receptor abundance may depend on receptor uncoupling and heterologous regulation by PKA.

Citing Articles

Postmortem evidence of decreased brain pH in major depressive disorder: a systematic review and meta-analysis.

Hagihara H, Miyakawa T Transl Psychiatry. 2024; 14(1):460.

PMID: 39496593 PMC: 11535390. DOI: 10.1038/s41398-024-03173-7.

Ameliorating effect of chotosan and its active component, hook, on lipopolysaccharide-induced anxiety-like behavior in mice.

Okawa Y, Ushio S, Izushi Y, Kitamura Y, Zamami Y, Sendo T Front Pharmacol. 2024; 15:1471602.

PMID: 39295939 PMC: 11408319. DOI: 10.3389/fphar.2024.1471602.

Linking alterations in estrogen receptor expression to memory deficits and depressive behavior in an ovariectomy mouse model.

Baek D, Kang J, Lee J, Lee E, Son C Sci Rep. 2024; 14(1):6854.

PMID: 38514828 PMC: 10958029. DOI: 10.1038/s41598-024-57611-z.

Activity of Protein Kinase A in the Frontal Cortex in Schizophrenia.

Sahay S, Henkel N, Vargas C, McCullumsmith R, ODonovan S Brain Sci. 2024; 14(1).

PMID: 38248228 PMC: 10813263. DOI: 10.3390/brainsci14010013.

Genetic polymorphisms in the serotonin, dopamine and opioid pathways influence social attention in rhesus macaques (Macaca mulatta).

Howarth E, Szott I, Witham C, Wilding C, Bethell E PLoS One. 2023; 18(8):e0288108.

PMID: 37531334 PMC: 10395878. DOI: 10.1371/journal.pone.0288108.

References

Jans L, Riedel W, Markus C, Blokland A . Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry. 2006; 12(6):522-43. DOI: 10.1038/sj.mp.4001920. View

Hrdina P, Demeter E, Vu T, Sotonyi P, Palkovits M . 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 1993; 614(1-2):37-44. DOI: 10.1016/0006-8993(93)91015-k. View

Kendler K . Major depression and generalised anxiety disorder. Same genes, (partly)different environments--revisited. Br J Psychiatry Suppl. 1996; (30):68-75. View

Stockmeier C . Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res. 2003; 37(5):357-73. DOI: 10.1016/s0022-3956(03)00050-5. View

Akin D, Hal Manier D, Sanders-Bush E, Shelton R . Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology. 2004; 29(11):2081-7. DOI: 10.1038/sj.npp.1300505. View

Arango V, Ernsberger P, Marzuk P, Chen J, Tierney H, Stanley M . Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry. 1990; 47(11):1038-47. DOI: 10.1001/archpsyc.1990.01810230054009. View

Lemonde S, Turecki G, Bakish D, Du L, Hrdina P, Bown C . Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci. 2003; 23(25):8788-99. PMC: 6740417. View

Pandey G, Dwivedi Y, Rizavi H, Ren X, Pandey S, Pesold C . Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry. 2002; 159(3):419-29. DOI: 10.1176/appi.ajp.159.3.419. View

Li Z, Ichikawa J, Huang M, Prus A, Dai J, Meltzer H . ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Psychopharmacology (Berl). 2005; 183(2):144-53. DOI: 10.1007/s00213-005-0170-9. View

10.

Shelton R, Hal Manier D, Peterson C, Ellis T, Sulser F . Cyclic AMP-dependent protein kinase in subtypes of major depression and normal volunteers. Int J Neuropsychopharmacol. 2001; 2(3):187-192. DOI: 10.1017/S1461145799001509. View

11.

Plotsky P, Owens M, Nemeroff C . Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am. 1998; 21(2):293-307. DOI: 10.1016/s0193-953x(05)70006-x. View

12.

Dwivedi Y, Conley R, Roberts R, Tamminga C, Pandey G . [(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims. Am J Psychiatry. 2002; 159(1):66-73. DOI: 10.1176/appi.ajp.159.1.66. View

13.

Ichikawa J, Meltzer H . R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum. J Pharmacol Exp Ther. 1999; 291(3):1227-32. View

14.

Akin D, Hal Manier D, Sanders-Bush E, Shelton R . Signal transduction abnormalities in melancholic depression. Int J Neuropsychopharmacol. 2004; 8(1):5-16. DOI: 10.1017/S146114570400478X. View

15.

Arango V, Huang Y, Underwood M, Mann J . Genetics of the serotonergic system in suicidal behavior. J Psychiatr Res. 2003; 37(5):375-86. DOI: 10.1016/s0022-3956(03)00048-7. View

16.

Simon J, Nemeroff C . Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder. J Clin Psychiatry. 2005; 66(10):1216-20. DOI: 10.4088/jcp.v66n1002. View

17.

Stanley M, Mann J . Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. 1983; 1(8318):214-6. DOI: 10.1016/s0140-6736(83)92590-4. View

18.

Mann J, Brent D, Arango V . The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology. 2001; 24(5):467-77. DOI: 10.1016/S0893-133X(00)00228-1. View

19.

Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, Kato T . Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res. 2007; 60(2):184-91. DOI: 10.1016/j.neures.2007.10.010. View

20.

Hrdina P, Du L . Levels of serotonin receptor 2A higher in suicide victims?. Am J Psychiatry. 2001; 158(1):147-8. DOI: 10.1176/appi.ajp.158.1.147-a. View